1 / 8

NVAC Pandemic Influenza Working Group

NVAC meeting, February 2005. NVAC Pandemic Influenza Working Group. Ben Schwartz NVPO. Current Status of Pandemic Planning & Preparedness. Draft HHS plan released in August for public comment Several key issues require decisions

bellona
Download Presentation

NVAC Pandemic Influenza Working Group

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NVAC meeting, February 2005 NVAC Pandemic Influenza Working Group Ben Schwartz NVPO

  2. Current Status of Pandemic Planning & Preparedness • Draft HHS plan released in August for public comment • Several key issues require decisions • Many comments were requests for more specifics and more guidance • Preparedness activities are ongoing • H5N1 vaccine clinical trials • Contracts for egg-security and diversification of U.S. production • Working groups developed at CDC to support states

  3. Next Steps – Critical Needs • Provide options to HHS to guide decision-making • Vaccine and antiviral priority groups • Vaccine purchase and distribution • Revise plan and provide more specific guidance • Move from a focus on planning to preparedness • Develop guidelines, algorithms, materials, software programs that can be used in a pandemic • Obtain input from and increase engagement with stakeholder organizations

  4. The NVAC Pandemic Influenza Working Group • Developed initially to coordinate NVAC comments on the draft plan • Proposed new role • Analyze options for key decisions • Provide input to NVPO on revisions to the plan • Obtain stakeholder perspectives on pandemic planning and preparedness • Increase engagement of stakeholders and increase communication between HHS and participating organizations

  5. Proposed Working Group Membership • NVAC members (Dr. Hinman, Chair) • Representatives from • Federal agencies (FDA, NIH, CDC, HRSA, VA) • Federal advisory committees (ACIP, HICPAC, VRBPAC) • Medical societies (AAP, AAFP, ACP, IDSA, AMA) • Healthcare organizations (AHA, AHIP) • Public health organizations (ASTHO, CSTE, NACCHO) • Public Health Agency of Canada • Ethicists

  6. Working Group Approach, 1 • Establish subgroups to analyze issues and develop options for presentation to NVAC • Vaccine priority groups for a pandemic – joint group with ACIP • Antiviral priority groups and strategies • Other subgroups may be formed based on needs identified by HHS, WG members, or stakeholders • WG will consider subgroup analyses, provide input on issues that affect stakeholders broadly, and comment on guidelines & materials

  7. Working Group Approach, 2 • Anticipate ~2 WG meetings per year • Subgroups will likely have an additional meeting • Most communication will be by conference call and e-mail • NVPO will provide staff and admin. support • Initial presentation on priority groups for vaccine and antiviral drugs at June NVAC and ACIP meetings

  8. Identifying Working Group Members • Letters to stakeholder groups to be sent this week • Where appropriate, NVAC members and liaisons are encouraged to represent their organizations • We hope to form the Working Group before the end of February for an initial meeting in mid-March

More Related